-
CNTX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Context Therapeutics (CNTX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 84.80 mm | 84.80 mm | 84.80 mm | 84.80 mm | 84.80 mm | 84.80 mm |
Cash burn (monthly) | 5.58 mm | (no burn) | 6.23 mm | 2.71 mm | 644.44 k | 1.41 mm |
Cash used (since last report) | 28.25 mm | n/a | 31.57 mm | 13.74 mm | 3.26 mm | 7.12 mm |
Cash remaining | 56.55 mm | n/a | 53.23 mm | 71.07 mm | 81.54 mm | 77.68 mm |
Runway (months of cash) | 10.1 | n/a | 8.5 | 26.2 | 126.5 | 55.2 |
13F holders | Current |
---|---|
Total holders | 20 |
Opened positions | 8 |
Closed positions | 24 |
Increased positions | 1 |
Reduced positions | 6 |
13F shares | Current |
---|---|
Total value | 34.42 bn |
Total shares | 26.76 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Nextech Crossover I GP S.a r.l. | 7.42 mm | $13.21 mm |
Great Point Partners | 6.93 mm | $13.59 bn |
Vanguard | 3.74 mm | $7.34 bn |
BEN Franklin Resources | 1.85 mm | $3.69 bn |
Ally Bridge | 1.76 mm | $3.44 bn |
Affinity Asset Advisors | 1.32 mm | $2.59 bn |
Hudson Bay Capital Management | 1.00 mm | $2.17 mm |
BlackRock | 848.97 k | $1.66 bn |
Martin A. Lehr | 820.19 k | $0.00 |
Geode Capital Management | 575.90 k | $1.13 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Feb 25 | Jennifer Lynn Minai-Azary | Stock Option Common Stock | Grant | Acquire A | No | No | 0.81 | 371,800 | 301.16 k | 371,800 |
13 Feb 25 | Alex C. Levit | Stock Option Common Stock | Grant | Acquire A | No | No | 0.81 | 349,900 | 283.42 k | 349,900 |
13 Feb 25 | Ullmann Claudio Dansky | Stock Option Common Stock | Grant | Acquire A | No | No | 0.81 | 174,960 | 141.72 k | 174,960 |
13 Feb 25 | Martin A. Lehr | Stock Option Common Stock | Grant | Acquire A | No | No | 0.81 | 802,700 | 650.19 k | 802,700 |
13 Jan 25 | Andy Pasternak | Stock Option Common Stock | Grant | Acquire A | No | No | 1.03 | 20,685 | 21.31 k | 20,685 |